Lineage Cell Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 169.8M |
| FY2023 | 172.7M |
| FY2024 | 200.2M |
| FY2025 | 230.1M |
| FY2026 | 249.1M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 169.8M |
| FY2023 | 172.7M |
| FY2024 | 200.2M |
| FY2025 | 230.1M |
| FY2026 | 249.1M |